Press Releases


New ASCO Studies Offer Evidence for Use of Circulating Tumor Cells as a Prognostic Biomarker for Advanced Prostate and Breast Cancer

Results from prospective trials show a "clear prognostic value" for CTC counts

continue →

Topics: CTCs, CELLSEARCH, metastatic breast cancer, prostate cancer, ASCO


Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19

Enumeration of Circulating Endothelial Cells (CECs) with CELLSEARCH platform may offer a new tool for investigating the role of the damaged endothelium in SARS-CoV-2 infection and clinical manifestation.

continue →

Topics: CELLSEARCH, COVID-19, CECs, Coronavirus, Circulating Endothelial Cells


CellSearch Studies at ASCO Show Potential Predictive Role for Circulating Tumor Cells in Metastatic Breast Cancer

Liquid biopsy data reveals “intriguing” association between ESR1 mutations, HER2 alterations and prognosis

continue →

Topics: CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer


New CellSearch Data To Be Presented at AACR Deepens Understanding of Metastatic Breast Cancer

Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker

continue →

Topics: deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer, lynphoma, CTC cluster, melanoma


Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells

Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression

continue →

Topics: FFPE, deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, Multiple myeloma, CMMCs


New Studies Using CELLSEARCH Circulating Tumor Cell Test to be Featured at San Antonio Breast Cancer Symposium

Research Adds to Growing Evidence of Clinical Utility of CTCs for the management of Metastatic Breast Cancer Patients

continue →

Topics: CTCs, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer


A robust method to study cancer heterogeneity in liquid biopsy

Copy Number Alteration Profiling of Single Circulating Tumor Cells which May Be used to Predict Response to Therapy

continue →

Topics: CTCs, DEPArray NxT, NGS, CELLSEARCH, Liquid biopsy, Precision Medicine, low-pass, copy number alteration


Menarini-Silicon Biosystems Completes Acquisition of CELLSEARCH® Assets

Liquid Biopsy Test for Circulating Tumor Cells Marks Its First Entry into U.S. Diagnostics Market

continue →

Topics: CTCs, deparray, CELLSEARCH, acquisition, CTC test, Liquid biopsy


Menarini-Silicon Biosystems to Acquire CELLSEARCH® CTC System

Only FDA-Cleared CTC test to join Company’s Portfolio of Diagnostics

continue →

Topics: CTCs, single-cell isolation, deparray, CELLSEARCH